Reuters logo
BRIEF-Hunan Er-kang Pharmaceutical sees Q1 2017 net profit up 18-38 pct
April 10, 2017 / 9:15 AM / 6 months ago

BRIEF-Hunan Er-kang Pharmaceutical sees Q1 2017 net profit up 18-38 pct

April 10 (Reuters) - Hunan Er-kang Pharmaceutical Co Ltd :

* Sees net profit for Q1 2017 to increase by 18 percent to 38 percent, or to be 198.4 million yuan to 232.0 million yuan, compared to net profit of the same period in 2016 (168.1 million yuan)

* Comments that increased sales of main business is main reason for the forecast

Source text in Chinese: goo.gl/mZPtjd

Further company coverage: (Beijing Headline News)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below